RT @TallAllen: @SbrtSean 2/ 18F-PSMA-1007 (which has similarly low urinary excretion) found local relapse (after RP) at 37%, which was high…
@SbrtSean 2/ 18F-PSMA-1007 (which has similarly low urinary excretion) found local relapse (after RP) at 37%, which was higher than the 4% with Ga68PSMA11 in another study https://t.co/bWgACvOnAC BUT, a direct comparison found no diff in local tracer uptak
RT @LujanPomponio: 18F-PSMA- PET / CT puede detectar Ca Prostata recurrente en un alto porcentaje de pacientes con recaída bioquímica. La…
RT @LujanPomponio: 18F-PSMA- PET / CT puede detectar Ca Prostata recurrente en un alto porcentaje de pacientes con recaída bioquímica. La…
18F-PSMA- PET / CT puede detectar Ca Prostata recurrente en un alto porcentaje de pacientes con recaída bioquímica. La probabilidad de una exploración PET / TC 18F-PSMA- patológica parece ser alta incluso en pacientes con un nivel bajo de PSA ≤0.5 ng /ml
RT @radiolobt: Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer "Germany couldn't win…
RT @radiolobt: Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer "Germany couldn't win…
RT @radiolobt: Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer "Germany couldn't win…
At least one great success this year! Oh no, wait! There was #wimbledon2018 too👍🎾🇩🇪 https://t.co/R1BNbGiwMJ
Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer "Germany couldn't win the World Cup, however they continue to dominate the #PSMA literature. Another #PSMA paper from 🇩🇪 👏" https://t.co/dMEVCXLIvZ